APA (7th ed.) Citation

M, K., L, X., E, R., A, B., D, S., A, K., . . . K, S. (2024). FDA-approved disulfiram as a novel treatment for aggressive leukemia. Journal of molecular medicine (Berlin, Germany), 102(4), 507. https://doi.org/10.1007/s00109-023-02414-4

Chicago Style (17th ed.) Citation

M, Karsa, et al. "FDA-approved Disulfiram as a Novel Treatment for Aggressive Leukemia." Journal of Molecular Medicine (Berlin, Germany) 102, no. 4 (2024): 507. https://doi.org/10.1007/s00109-023-02414-4.

MLA (9th ed.) Citation

M, Karsa, et al. "FDA-approved Disulfiram as a Novel Treatment for Aggressive Leukemia." Journal of Molecular Medicine (Berlin, Germany), vol. 102, no. 4, 2024, p. 507, https://doi.org/10.1007/s00109-023-02414-4.